Thiogenesis Therapeutics Corp(TTI-X)
TSX Venture

Today's Change
Delayed Last Update

Thiogenesis Therapeutics Corp

4 King Street West
Suite 401
Toronto ON M5H 1B6 CAN
P: 647-846-7766
https://www.thiogenesis.com

Sectors & Indices

Sector
Industry
Employees

Profile

Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic drug product candidates, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the company's flagship drug product candidate, was developed to address the obstacles facing existing thiol-based drugs, their short half-live and side effects.

Key Executives

NameTitle
Patrice RiouxCEO/Co-Founder/Co-President/Director
Brook G. RigginsCFO/Director/Secretary

More from The Globe

Energy sector insiders are ramping up their bets against oil bears
Ted Dixon
Bullish potential on Intact Financial Corp.
Monica Rizk
top links
Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
Future headquarters of Ontario Power Generation, Oshawa, March 2025.
trade secrets
Where will tech stocks go from here?
Happy man investor. Crypto currency up trend. Growth chart concept. Trade Chart. Cryptocurrency mining, bitcoin exchange, blockchain and marketing technology, internet money flat vector illustration.
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored
Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
the mover
Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
number cruncher
Top U.S. stocks ranked by Trading Central’s quantitative model
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.